"There’s nothing like Australia.’’ So states the country’s official tourism website. But, ironically, that motto also applies to the debate over transparency in the relationships between life sciences companies and healthcare professionals. This debate is rapidly becoming a global contest fought out in North America, Europe, Asia, and the Pacific. While some countries have adopted legislatively-imposed reporting requirements, others rely on requirements created by industry associations. The debate between advocates of transparency legislation, who claim their approach willlead to cost savings and a reduction in corruption, and supporters of industry self-regulation, who assert their model is more efficient and has the potential for global uniformity, continues to rage.
Please click here to read the full article.